UC Davis Stem Cell (@ucdavisstemcell) 's Twitter Profile
UC Davis Stem Cell

@ucdavisstemcell

The UC Davis Institute for Regenerative Cures (IRC) is a hub for cell & gene therapy. UCD has 51 currently active cell and/or gene therapy clinical trials.

ID: 3145577612

linkhttp://www.ucdmc.ucdavis.edu/stemcellresearch/ calendar_today09-04-2015 03:25:22

7,7K Tweet

6,6K Followers

4,4K Following

Alliance for Regenerative Medicine (ARM) (@alliancerm) 's Twitter Profile Photo

3/5 Orca Bio announced positive results from its pivotal phase 3 study of its T-cell immunotherapy and indicated it would seek a 2025 regulatory submission in the US. orcabio.com/orca-bio-annou…

Alliance for Regenerative Medicine (ARM) (@alliancerm) 's Twitter Profile Photo

4/5 Novartis published new data demonstrating meaningful efficacy and safety in broad patient populations for its gene therapy to treat SMA. novartis.com/news/media-rel…

Eric Topol (@erictopol) 's Twitter Profile Photo

I wouldn't have anticipated a Lupus self-directed antibody might someday turn out to be an anti-cancer treatment science.org/doi/10.1126/sc…

I wouldn't have anticipated a Lupus self-directed antibody might someday turn out to be an anti-cancer treatment  science.org/doi/10.1126/sc…
Dr. Jan Nolta (@jan_nolta) 's Twitter Profile Photo

This morning in our #stemcell & #genetherapy seminar series we are fortunate to have UCD Health Dept. Dermatology Dr. Sasha Shafikhani Sasha Shafikhani discussing his important work in diabetic wound healing and infection. health.ucdavis.edu/dermatology/fa…

This morning in our #stemcell &amp; #genetherapy seminar series we are fortunate to have UCD Health Dept. Dermatology Dr. Sasha Shafikhani <a href="/SashaShafikhani/">Sasha Shafikhani</a> discussing his important work in diabetic wound healing and infection. 

health.ucdavis.edu/dermatology/fa…
UC Davis Stem Cell (@ucdavisstemcell) 's Twitter Profile Photo

From our outstanding colleague Dr. Maneesh Dave @UCDavis: MSCs mediate long-term efficacy in a Crohn's disease model by sustained anti-inflammatory macrophage programming vi… pubmed.ncbi.nlm.nih.gov/38245543/

STEM CELLS Journal (@stemcellsjournl) 's Twitter Profile Photo

A serum- and feeder-free differentiation process, suitable for large-scale production of iPSC-derived CD4sp and regulatory T cells, is reported here. doi.org/10.1093/stmcls…

A serum- and feeder-free differentiation process, suitable for large-scale production of iPSC-derived CD4sp and regulatory T cells, is reported here.
doi.org/10.1093/stmcls…
Eric Topol (@erictopol) 's Twitter Profile Photo

It has taken decades to get to this point, but stem cells for Parkinson's disease showing promise in 2 clinical trials nature.com/articles/d4158… nature.com/articles/s4158… nature.com/articles/s4158…

It has taken decades to get to this point, but stem cells for Parkinson's disease showing promise in 2 clinical trials
nature.com/articles/d4158…
nature.com/articles/s4158…
nature.com/articles/s4158…
STEM CELLS Journal (@stemcellsjournl) 's Twitter Profile Photo

Optimizing approaches for targeted integration of transgenic cassettes by integrase-mediated cassette exchange in mouse and human stem cells doi.org/10.1093/stmcls…

Optimizing approaches for targeted integration of transgenic cassettes by integrase-mediated cassette exchange in mouse and human stem cells
doi.org/10.1093/stmcls…
Eric Topol (@erictopol) 's Twitter Profile Photo

Cells differ in their cell-division cycle pace. But only now has it been shown that those types with faster cycles are more susceptible to cancer. nature.com/articles/d4158…

UC Davis Research (@ucdavisresearch) 's Twitter Profile Photo

Have a look at how research UC Davis continues to impact daily lives and shape our future. #UCDavisDelivers #UCDD #ResearchImpact research.ucdavis.edu/research-progr…

Bruce Levine, Ph.D. šŸ‡ŗšŸ‡¦šŸ„¼šŸ”¬šŸ§¬šŸ§ŖšŸ’‰ (@bllphd) 's Twitter Profile Photo

When are we going to see progress for CAR T in solid tumors?", I'm often asked. More to do for sure, but progress is clear. Intracerebroventricular bivalent CAR T cells targeting EGFR and IL-13Rα2 in recurrent glioblastoma: a phase 1 trial Penn Medicine DrORourke

When are we going to see progress for CAR T in solid tumors?", I'm often asked. More to do for sure, but progress is clear.
Intracerebroventricular bivalent CAR T cells targeting EGFR and IL-13Rα2 in recurrent glioblastoma: a phase 1 trial
<a href="/PennMedicine/">Penn Medicine</a> <a href="/DrORourke2/">DrORourke</a>
Dr. Jan Nolta (@jan_nolta) 's Twitter Profile Photo

To our colleagues and students in #Celltherapy and #Genetherapy, I know MANY of you have submitted applications to move outside of the USA due to the major cuts to NIH funding, and it has seemed hopeless to stay here, due to the "war on science". Please watch this video, give

NIH Funding (@nihfunding) 's Twitter Profile Photo

Support for Research Excellence First Independent Research (SuRE-First) Award (R16 - Clinical Trial Not Allowed) grants.nih.gov/grants/guide/p…

NIH (@nih) 's Twitter Profile Photo

#NIH released a #FundingOpportunity for the NIH Director’s Pioneer Award to support researchers pursuing bold and innovative approaches to major challenges. Learn more about this exciting initiative: bit.ly/3FYVRKI

#NIH released a #FundingOpportunity for the NIH Director’s Pioneer Award to support researchers pursuing bold and innovative approaches to major challenges. Learn more about this exciting initiative: bit.ly/3FYVRKI